Background illustration for clinical trials search

Paid Clinical Trials Edmonton

Discover 436 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

for
CNS Embryonal Tumor, CNS, Medulloblastoma,
Location: Edmonton, Calgary, Vancouver, Winnipeg, London,
Sponsor: C17 Council

Sex: All

Age: 0 - 6

Code: NCT06942039

Early Phase 1, Recruiting
Active & Responsive

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

for
Lichen Planopilaris
Location: Edmonton, Mill Creek WA, Portland OR, Murray UT,
Sponsor: Priovant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07532603

Phase 2, Phase 3, Recruiting
Active & Responsive

The Canadian Lung Outcomes in Users of Vaping Devices Study

for
Small Airways Diseases, Vaping, Vaping Related Disorder,
Location: Edmonton, Vancouver, Ottawa
Sponsor: University of British Columbia

Sex: All

Age: 12+

Code: NCT06819969

Recruiting
Active & Responsive

Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance

for
Obesity, Childhood, Insulin Resistance
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 12 - 18

Code: NCT04578652

Phase 3, Recruiting
Active & Responsive

ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial

for
Endometrial Cancer
Location: Edmonton, Toronto
Sponsor: University of Alberta

Sex: Female

Age: 18+

Code: NCT06038032

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

for
Diabetes Mellitus, Type 1
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18 - 55

Code: NCT06748963

Recruiting
Active & Responsive

SYNERGIC-2 Trial (SYNchronizing, Exercises and Remedies to GaIn Cognition@Home)

for
Mild Cognitive Impairment
Location: Edmonton, Vancouver, London, Waterloo, Toronto, Ottawa,
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sex: All

Age: 60 - 70+

Code: NCT05375513

Recruiting
Active & Responsive

Feasibility Trial for a Right Ventricular Failure Platform Trial

for
Pulmonary Hypertension, Right Ventricular Dysfunction,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06570473

Phase 2, Recruiting
Active & Responsive

Effect of Hi-OxSR for the Treatment of Post COVID Condition

for
Long COVID, Post COVID-19 Condition,
Location: Edmonton, Toronto, Sherbrooke
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06928506

Recruiting
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Edmonton, Calgary, Kalispell MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Edmonton, Seattle WA, Vancouver WA, Aurora CO,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Edmonton, Spokane WA, Seattle WA, Sandy City UT,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase 3, Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Edmonton, Saskatoon, Seattle WA, Boise ID,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase 3, Recruiting
Active & Responsive

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

for
Multiple Myeloma
Location: Edmonton, London, Toronto, Montreal, Halifax,
Sponsor: Canadian Myeloma Research Group

Sex: All

Age: 65+

Code: NCT05272826

Phase 2, Recruiting
Active & Responsive

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy),
Location: Edmonton, Montreal, Baltimore MD, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06535607

Phase 2, Recruiting
Active & Responsive

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

for
Advanced Solid Tumors
Location: Edmonton, Milwaukee WI, Grand Rapids MI, Hamilton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05067283

Phase 1, Recruiting
Active & Responsive

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

for
Carcinoma, Non-Small-Cell Lung
Location: Edmonton, Fargo ND, Sioux Falls SD, Columbus OH,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04165798

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Edmonton, Calgary, Lethbridge, New Westminster,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase 3, Recruiting
Active & Responsive

Use of Passive Myofunctional Appliances for Snoring and Mild Obstructive Sleep Apnea

for
Sleep Apnea, Obstructive
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT05497180

Phase 1, Recruiting
Active & Responsive

Photobiomodulation for Pediatric Hypertrophic Tonsils

for
Pediatric Sleep Apnea, Obstructive Sleep Apnea,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 6 - 12

Code: NCT05459935

Recruiting